ISTURISA® (osilodrostat) Now Available in Canada for the Treatment of Cushing's Disease

Recordati Rare Diseases Canada Inc. announced today the Canadian product availability of ISTURISA® (osilodrostat) for the treatment of adult patients with Cushing's disease who have persistent or ...

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman

Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter ("CRL" ...
Healio

FDA declines to approve relacorilant for hypertension linked to hypercortisolism

Please provide your email address to receive an email when new articles are posted on . The FDA issued a complete response letter for relacorilant to treat hypertension tied to hypercortisolism. The ...
pharmaphorum

FDA declines to approve Corcept's rare disorder drug

As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept Therapeutics with a decision not to approve relacorilant, a drug for a rare hormonal disorder that ...

Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts?

Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the most promising growth stocks according to analysts. According to ...
BioWorld

Corcept looks to ovarian cancer as relacorilant gets CRL in Cushing

The U.S. FDA dashed hopes that Corcept Therapeutics Inc. might be able to launch its selective glucocorticoid receptor antagonist in two indications in 2026, issuing a complete response letter for ...
Opinion

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday

A competitor's setback was Xeris Biopharma 's ( XERS +7.39%) gain on Hump Day. On news that a potential commercial threat to one of its three commercialized drugs had been neutralized (at least for ...
E! News on MSN

Jay Leno Was Asked If He'd Get a Girlfriend Amid Wife’s Health Battle

Jay Leno shared he was stunned to be asked if he was planning on getting a girlfriend while acting as a caregiver to his wife ...

USWNT star Sam Coffey's Man City move highlights Europe's growing pull as NWSL confronts talent outflow

Coffey's arrival only boosts the international power on the roster as she joins Kerolin, Miedema, Bunny Shaw, and Yui ...
Barchart on MSN

The FDA just snubbed Corcept Therapeutics. Should you buy the dip in CORT stock or stay far away?

Corcept Therapeutics (CORT) crashed on Dec. 31 after the Food and Drug Administration (FDA) rejected its application for relacorilant, its investigational treatment for Cushing’s syndrome. The ...

Japan regulator says it may start Chubu Electric nuclear review from scratch

Japan's nuclear regulator said on Wednesday it could restart the screening of Chubu Electric Power's Hamaoka plant from ...

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

ABOUT CRINETICS PHARMACEUTICALS Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science ...